GlaxoSmithKline PLC GSK (U.K.: London)

• Add to My Journal
• Help

comprehensive quote
4:35 PM 10/18/2013
(Local Exchange Timestamp)

1,578.50 GBp + 4.50 (0.29%)

• 3Y
• 1Y
• 6M
• 1M
• 10D
• 5D

10/18 :

• Open 1,582.50
• High 1,588.00
• Low 1,574.50
• Vol 9.955M

2,000

1,800

1,600

1,400

1,200

13

N

F

A

J

A

1,590

1,585

1,580

1,575

1,570

9a

10a

11a

12p

1p

2p

3p

4p

Relative Performance: 10/18
GSK	+0.29%
DJIA	+0.18%
Health Care	-0.31%

Market News:

• S&P 500 Ends at New Record

Show More & Compare

• Quote
• News
• Chart
• Research and Ratings
• Company & People
• Financials

• QUICK LINKS GSK :
• Interactive Charting
• Insider Trading
• Options
• Historical Prices
• Time & Sales Data
• Ownership

Latest News

• WSJ/Dow Jones
• MarketWatch
• Press Releases

• Corruption Currents: From Staying Put to Yeung Testifies

  Mark Reilly, GlaxoSmithKline PLC's former head of operations in China, is aiding the Chinese with their bribery probe and was asked to stay in China.
  

  • 10/16/13
  • WSJ Blogs

• GSK Says Former China Chief Assisting Authorities in Bribery Probe

  • 10/16/13
  • The Wall Street Journal

• Amarin ADRs Take a Hit After FDA Releases Report on Cholesterol Drug

  • 10/11/13
  • Dow Jones Newswires

• Corruption Currents: From Bagfuls of Cash to the ABCs of Education Bribery

  • 10/10/13
  • WSJ Blogs

• GlaxoSmithKline Cut to Underperform From Neutral by Credit Suisse

  • 10/10/13
  • Dow Jones Newswires

• U.S. Hot Stocks: Alcoa, Yum Brands, Callidus Software Active in Late Trading

  • 10/08/13
  • Dow Jones Newswires

• U.S. Hot Stocks: Tower Group, Jamba, J.C. Penney, Arkansas Best

  • 10/08/13
  • Dow Jones Newswires

• Stocks to Watch: Tower Group, Jamba, J.C. Penney

  • 10/08/13
  • WSJ Blogs

• Glaxo to Seek Approval for Malaria Vaccine

  • 10/07/13
  • The Wall Street Journal
  • 1 Comment

• Glaxo Submits Variation to Marketing Authorization for Leukaemia Drug

  • 10/04/13
  • Dow Jones Newswires

• A New Challenge for Multinationals in China: Mao-era Politics

  • 09/30/13
  • The Wall Street Journal
  • 40 Comments

• Corruption Currents: From Historic Phone Calls to Data Havens Seek Business

  • 09/30/13
  • WSJ Blogs

• GSK Sells Thrombosis Brands

  • 09/30/13
  • The Wall Street Journal

• GlaxoSmithKline to Sell Thrombosis Brands, Site for GBP0.7B

  • 09/30/13
  • Dow Jones Newswires

• Carbon Fiber Leader Toray Signs 2 Separate Deals

  • 09/27/13
  • The Wall Street Journal

Index Affiliation

• The Global Dow

• Dow Jones Global Titans Index

• Dow Jones Global Index

• FTSE 100 Index

• Dow Jones Global Total Stock Market Index

• Dow Jones Health Care Titans 30 Index

• Dow Jones Titans Sector Composite Index

• Dow Jones Global Large-Cap Index

Key Stock Data

• Dividend Yield GSK has not issued dividends in more than 1 year.
• P/E Ratio 19.27 Trailing 12 months
• Market Cap 76.63 Billion GBP
• Shares Outstanding 4.89 Billion
• Public Float 4.81 Billion

Dividends

• GSK has not issued dividends in more than 2 years

Related Information

• Historical Prices

• Annual Reports

• Market Data Center

Footnotes:

U.K.: London prices are delayed by 15 minutes. International indexes are delayed as per exchange requirements. Quote data, except U.S. stocks, provided by SIX Financial Information. U.S. stock quote data provided by Dow Jones.
LSS = U.K.: London
Copyright 2013 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals.